Ledger.Open graph →
SEC Form D · filed October 19, 2015

Envisia Therapeutics, Inc

Offering
$5.1M
Sold
$4.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MORRISVILLE, NC
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Ed Mathers · MORRISVILLE, NCDirectorBen Yerxa · MORRISVILLE, NCExecEric Linsley · MORRISVILLE, NCExecStephen Bloch · MORRISVILLE, NCDirectorNeal Fowler · MORRISVILLE, NCDirectorGary Phillips · MORRISVILLE, NCDirectorWilliam L. Moore · Hendersonville, TNDirectorRonald C. Filer, Jr · Hendersonville, TNExecTed Smith · Crestwood, KYDirectorRobert Cryan · Lake Forrest Park, WADirectorChristopher S. O'Connor · Wildwood, MODirectorAdrienne Graves · San Diego, CADirectorSeth Rudnick · Rowayton, CTDirectorCharles Heffernan · Seattle, WADirectorKarl R. Miller, Jr · Wilsonville, ORExec · DirectorMahmood Sher-Jan · Portland, ORExecLance De Jersey · St. Peter Port, Y7DirectorMichael Studer · St. Peter Port, Y7DirectorDaniel Stopher · St. Peter Port, Y7ExecAdrienne Graves · San Diego, CADirectorSeth Rudnick · MORRISVILLE, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗